Explore more Johnson & Johnson sites:
World of Well
5 Ways We're Helping Build a World of Well
5 Ways We're Helping Build a World of Well
At Johnson & Johnson, we're tackling some of the world's toughest health challenges. From work to eliminate cancer and innovate surgery to a commitment to invest in health equity solutions, click on the links below to learn more about our efforts in five key areas of healthcare to help create a world of well.
Jump to:
ealth is the one thing that every single one of us on earth needs—and that makes everything in life possible. It means we can live life fully. It means we can care for the people we love. It means we can be together.
When we founded our company in 1886, it was guided by a singular mission: help improve the health and well-being of humanity. And for the past 135 years, we've done this by driving and inspiring innovation and collaboration to help address some of the toughest health challenges facing people around the globe.
To this day, the idea of coming together across the company to help build a world of well touches everything we do—from the innovative cancer treatments our scientists work on to the surgical advances we help bring to operating rooms—so everyone can live and thrive in their own world of well.
Building a World of Well Through
Transformational Cancer Treatments
It's a health challenge that our scientists are relentlessly dedicated to addressing: the elimination of cancer. And one of the innovative ways we are approaching this challenge is through interception—our aim is to predict and preempt cancer at its earliest stages.
The research our scientists do spans everything from bladder cancer to lung cancer to blood cancer—and brings together the collective expertise of our pharmaceutical and medtech researchers to help change the trajectory of cancer for millions of people.
Our oncology promise: to advance cancer care through cutting-edge therapies and personalized approaches, like cell therapy. This is a more in-depth look at some of that work in action.
The research our scientists do spans everything from bladder cancer to lung cancer to blood cancer—and brings together the collective expertise of our pharmaceutical and medtech researchers to help change the trajectory of cancer for millions of people.
Our oncology promise: to advance cancer care through cutting-edge therapies and personalized approaches, like cell therapy. This is a more in-depth look at some of that work in action.
Watch Jeff's Story
"I'm Developing New Cancer Treatments"
Dr. Jeff Infante is a husband, father, oncologist and researcher who’s working to find the treatments of tomorrow with one goal in mind—eliminating cancer.
Ron was 54, running two businesses, and very active playing tennis three times a week when he was diagnosed with prostate cancer—a disease scientists at Johnson & Johnson are hard at work studying.
Building a World of Well Through
Life-Enhancing Digital Surgery
Johnson & Johnson has been pioneering surgical innovations for over 130 years, ever since we created the world’s first mass-produced sterile sutures in 1887.
Today we're continuing to drive advancements in surgery through digital solutions that are being designed to help make surgery smart, less invasive and more personalized so patients can experience better outcomes.
By leveraging the power of robotics—from an innovation that helps simplify knee-replacement surgery to a platform that's being designed to help physicians diagnose and eventually treat disease—here are some of the ways we're helping build a world of well for patients before, during and after surgery.
Today we're continuing to drive advancements in surgery through digital solutions that are being designed to help make surgery smart, less invasive and more personalized so patients can experience better outcomes.
By leveraging the power of robotics—from an innovation that helps simplify knee-replacement surgery to a platform that's being designed to help physicians diagnose and eventually treat disease—here are some of the ways we're helping build a world of well for patients before, during and after surgery.
Watch Desi's Story
"I'm Improving Knee-Replacement Surgeries"
Desi Ivanova was just 21 when she had knee surgery—an experience that inspired her to make the process better for other patients. Today she's an engineer using robotics to help make knee-replacement surgery less invasive and more personalized.
Innovator Spotlight
Ashley McEvoy is at the helm of the company's global Medical Devices Companies—overseeing everything from advancements in stroke care and joint surgery to the innovative Lung Cancer Initiative.
Building a World of Well Through
Better Eye Health
Sight is arguably one of our most treasured senses—yet over 2 billion people globally have a vision impairment. And in many cases these impairments could have been prevented through early diagnosis and treatment.
We are relentless in our pursuit to change statistics like these by helping people take care of their eyes throughout their lives with innovations designed to protect, correct and treat their eyesight.
From research aimed at helping kids with myopia to cataract solutions for older adults, we are with you every step of the way so you can see better, connect better and live better.
We are relentless in our pursuit to change statistics like these by helping people take care of their eyes throughout their lives with innovations designed to protect, correct and treat their eyesight.
From research aimed at helping kids with myopia to cataract solutions for older adults, we are with you every step of the way so you can see better, connect better and live better.
Watch Jaclyn's Story
"I'm Innovating Myopia Treatments for Kids"
Jaclyn Hernandez is on a very personal mission: to help stop the progression of myopia, also known as nearsightedness, before it leads to retinal diseases and even blindness. She's doing it for her daughters, who have myopia, and other children just like them.
Innovator Spotlight
Nearsightedness has become an epidemic, says Noel Brennan, Johnson & Johnson Vision Care, Inc. Myopia Control Research Fellow. But a partnership among global leaders in myopia is poised to help children have a brighter future.
Building a World of Well Through
Health Equity Advancements
A lack of access to affordable and quality healthcare. Implicit and explicit biases in medical care. These are just a couple of the reasons why people of color in the U.S. face stark inequities when it comes to getting the best care for themselves and their loved ones. And it's why we have committed over the next five years to invest in and promote health equity solutions aimed at helping eradicate racial and social injustice as a public health threat.
We call the initiative Our Race to Health Equity, and it's just one example of how we are focused on helping address inequities in healthcare for people of color and other individuals, like those within the LGBTQIA+ community.
Here is a look at some of the work, which also spans initiatives led by our Global Public Health team—and the dedicated people behind that work—taking place across our company to help put health within reach for everyone, everywhere.
We call the initiative Our Race to Health Equity, and it's just one example of how we are focused on helping address inequities in healthcare for people of color and other individuals, like those within the LGBTQIA+ community.
Here is a look at some of the work, which also spans initiatives led by our Global Public Health team—and the dedicated people behind that work—taking place across our company to help put health within reach for everyone, everywhere.
-
Advancing Health EquityIf people of color aren't well represented in healthcare, then communities o f color cannot receive truly equitable healthcare. These3 Ways Johnson & Johnson is Working to Boost the Number of Diverse Doctors unique programs are supporting physicians from racial minority groups so they can better support the patients who need them.
-
-
Innovator Spotlight
The U.S. has one of the highest maternal mortality rates in the developed world, with women of color especially at risk. Dr. Robyn R. Jones, Senior Medical Director at Johnson & Johnson, is determined to change that and find ways to address this crisis.
Building a World of Well Through
Pioneering Cell & Gene Therapies
We never stop working to create a future where disease is a thing of the past, and one way we do this is by working to advance potentially transformational innovations in medicine.
One promising area of research that we are deeply committed to progressing is cell and gene therapy. This includes gene therapy aimed at helping to address inherited retinal eye diseases and CAR-T cell therapy, which can leverage a patient's own white blood cells to target and kill a specific form of cancer.
And much of this work is taking place at specialized labs like our Janssen Cell Therapy Center. Read more about this cutting-edge facility and the inspiring research underway there to harness cell and gene therapies to tackle disease.
One promising area of research that we are deeply committed to progressing is cell and gene therapy. This includes gene therapy aimed at helping to address inherited retinal eye diseases and CAR-T cell therapy, which can leverage a patient's own white blood cells to target and kill a specific form of cancer.
And much of this work is taking place at specialized labs like our Janssen Cell Therapy Center. Read more about this cutting-edge facility and the inspiring research underway there to harness cell and gene therapies to tackle disease.
Innovator Spotlight
Dr. Sen Zhuang, Vice President, Oncology Clinical Research, Janssen Research & Development, is working on CAR-T therapy innovation. He shares how CAR-T, which harnesses a patient's white blood cells, can be used to fight specific forms of cancer.